Multiple sclerosis in the Iranian immigrant population of BC,Canada: prevalence and risk factors

Abstract

Background:

There is a well-documented increase in the risk of multiple sclerosis (MS) when migrating from a region of low prevalence to one of high prevalence.

Objective:

We present here an investigation of MS prevalence and candidate environmental and genetic risk factors among Iranian immigrants to British Columbia (BC), Canada.

Methods:

MS cases of Iranian ancestry were ascertained from a population-based Canadian study. We collected blood samples for genetic and serological analyses, and administered a personal history questionnaire to the cases.

Results:

The crude prevalence of MS in this population of Iranian ancestry was 287/100,000 (95% CI: 229 – 356/100,000). MS cases were more likely to have a history of infectious mononucleosis (odds ratio (OR) = 7.5; p = 0.005) and smoking (OR = 17.0; p < 0.0001), as compared to healthy controls from previous studies in Iran. Cases were also more likely than controls to have been born between April and September (OR = 2.1; p = 0.019).

Conclusion:

The prevalence of MS among Iranian immigrants to Canada is greater than the overall prevalence of MS in Iran by a factor of at least four, and is similar to that recently observed among Iranian immigrants in other western nations. No major genetic susceptibility variants were identified, suggesting the environment in Canada may be what is increasing the risk of MS in this population.

Keywords

Canada cohort studies environment epidemiology genetics Iranian multiple sclerosis prevalence risk factors

Get full access to this article

View all access options for this article.

References

Noseworthy

Lucchinetti

Rodriguez

. Multiple sclerosis. N Engl J Med 2000; 343: 938–952.

Ramagopalan

Dobson

Meier

. Multiple sclerosis: Risk factors, prodromes and potential causal pathways. Lancet Neurol 2010; 9: 727–739.

Koch-Henriksen

Sorensen

. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 2010; 9: 520–532.

Ahlgren

Lycke

Oden

. High risk of MS in Iranian immigrants in Gothenburg, Sweden. Mult Scler 2010; 16: 1079–1082.

Ahlgren

Oden

Lycke

. A nationwide survey of the prevalence of multiple sclerosis in immigrant populations of Sweden. Mult Scler 2012; 18: 1099–1107.

Guimond

Dyment

Ramagopalan

. Prevalence of MS in Iranian immigrants to British Columbia, Canada. J Neurol 2010; 257: 667–668.

Saadatnia

Etemadifar

Maghzi

. Multiple sclerosis in Isfahan, Iran. Int Rev Neurobiol 2007; 79: 357–375.

Etemadifar

Maghzi

. Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran. Mult Scler 2011; 17: 1022–1027.

Sadovnick

Risch

Ebers

. Canadian collaborative project on genetic susceptibility to MS, Phase 2: Rationale and method. Canadian Collaborative Study Group. Can J Neurol Sci 1998; 25: 216–221.

10.

Ramagopalan

Morris

Dyment

. The inheritance of resistance alleles in multiple sclerosis. PLoS Genet 2007; 3: 1607–1613.

11.

Shams

Amirzargar

Yousefi

. HLA class II (DRB, DQA1 and DQB1) allele and haplotype frequencies in the patients with pemphigus vulgaris. J Clin Immunol 2009; 29: 175–179.

12.

Wagner

Hanwell

Vieth

. An evaluation of automated methods for measurement of serum 25-hydroxyvitamin D. Clin Biochem 2009; 42: 1549–1556.

13.

Statistics Canada ethnic origin (101), age groups (8), sex (3) and selected demographic, cultural, labour force, educational and income characteristics (309), for the total population of Canada, provinces, territories, Census Metropolitan Areas and Census Agglomerations, 2006 Census - 20% Sample Data. Report, Statistics Canada, catalogue no. 97–564-XCB2006007, 2008.

14.

Willer

Dyment

Sadovnick

. Timing of birth and risk of multiple sclerosis: Population based study. Brit Med J 2005; 330: 120.

15.

Alonso

Cook

Maghzi

. A case-control study of risk factors for multiple sclerosis in Iran. Mult Scler 2011; 17: 550–555.

16.

Smestad

Sandvik

Holmoy

. Marked differences in prevalence of multiple sclerosis between ethnic groups in Oslo, Norway. J Neurol 2008; 255: 49–55.

17.

Beck

Metz

Svenson

. Regional variation of multiple sclerosis prevalence in Canada. Mult Scler 2005; 11: 516–519.

18.

Sahraian

Khorramnia

Ebrahim

. Multiple sclerosis in Iran: A demographic study of 8000 patients and changes over time. Eur Neurol 2010; 64: 331–336.

19.

Maghzi

Ghazavi

Ahsan

. Increasing female preponderance of multiple sclerosis in Isfahan, Iran: A population-based study. Mult Scler 2010; 16: 359–361.

20.

Kurtzke

. Geographic distribution of multiple sclerosis: An update with special reference to Europe and the Mediterranean region. Acta Neurol Scand 1980; 62: 65–80.

21.

Orton

Herrera

Yee

. Sex ratio of multiple sclerosis in Canada: A longitudinal study. Lancet Neurol 2006; 5: 932–936.

22.

Ghabaee

Bayati

Amri Saroukolaei

. Analysis of HLA DR2&DQ6 (DRB1*1501, DQA1*0102, DQB1*0602) haplotypes in Iranian patients with multiple sclerosis. Cell Mol Neurobiol 2009; 29: 109–114.

23.

Shahbazi

Roshandel

Ebadi

. High frequency of the IL-2–330 T/HLA-DRB1*1501 haplotype in patients with multiple sclerosis. Clin Immunol 2010; 137: 134–138.

24.

Shahbazi

Roshandel

Omidnyia

. Interaction of HLA-DRB1*1501 allele and TNF-alpha -308 G/A single nucleotide polymorphism in the susceptibility to multiple sclerosis. Clin Immunol 2011; 139: 277–281.

25.

Kollaee

Ghaffarpor

Ghlichnia

. The influence of the HLA-DRB1 and HLA-DQB1 allele heterogeneity on disease risk and severity in Iranian patients with multiple sclerosis. Int J Immunogenet 2012; 39: 414–422.

26.

Farjadian

Ota

Inoko

. The genetic relationship among Iranian ethnic groups: An anthropological view based on HLA class II gene polymorphism. Mol Biol Rep 2009; 36: 1943–1950.